priors.science/reviews/motor-neurone-disease-treatment

Motor Neurone Disease Treatment

The current evidence on 6 claims, ordered from most established to most contested. Each score is the panel’s evidence certainty: how firmly the literature supports the claim as stated.

6claims tracked
41primary papers reviewed
26 Oct 2026latest evidence review
2 Established · 2 Likely · 1 Uncertain · 1 Doubtful  |  four-reviewer panel · PICO Framework
ClaimStandingEvidence certaintyCorpus
Tofersen lowers neurofilamentDMTEstablished90%8
Riluzole prolongs survivalDMTEstablished86%6
Non-invasive ventilation prolongs survivalCareLikely80%7
Multidisciplinary care prolongs survivalCareLikely72%7
Edaravone slows declineDMTUncertain58%8
Sodium phenylbutyrate-taurursodiol prolongs survivalDMTDoubtful40%5
Track Motor Neurone Disease Treatment.
These claims are re-checked against new research as it is published. Track this topic for the full review, including each claim’s challenge and the papers behind it.
Track this topic →
Standing: what the evidence certainty means
Established≥ 85%Strong, consistent evidence. Unlikely to change.
Likely70–84%Well supported, with some gaps or indirect evidence.
Uncertain50–69%Mixed or limited evidence. Genuinely open.
Doubtful30–49%Little support; the weight of evidence leans against it.
Refuted< 30%The evidence contradicts it. Confidently false as stated.
A standing changes only when the score moves past a boundary by more than 4 points, the re-scoring noise floor; a score within 4 points of a boundary keeps its previous standing.